Screener
Crinetics Pharmaceuticals CRNX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
FAQ
- What is Crinetics Pharmaceuticals's free cash flow?
- Crinetics Pharmaceuticals (CRNX) reported free cash flow of -$125.52M in Q1 2026.
- How has Crinetics Pharmaceuticals's free cash flow changed year-over-year?
- Crinetics Pharmaceuticals's free cash flow decreased by 40.0% year-over-year, from -$89.69M to -$125.52M.
- What is the long-term trend for Crinetics Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's free cash flow has grown at a 44.1% compound annual growth rate (CAGR), from -$89.02M to -$383.68M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Crinetics Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude